Sylvia Acevedo filed a notice of proposed sale of common stock. The filing covers 2,200 common shares to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of $350,196.00, on or about 01/13/2026 on the NASDAQ exchange. These 2,200 shares were acquired as restricted stock from the issuer on 10/13/2025, with payment made the same day.
The notice also reports that Sylvia Acevedo previously sold 1,875 common shares on 12/05/2025 for gross proceeds of $347,193.75. The issuer reports 180,631,719 shares or units outstanding, providing context for the size of the planned sale.
Credo Technology Group Holding Ltd director and Chief Technology Officer Cheng Chi Fung reported multiple sales of ordinary shares on January 8, 2026. The transactions were executed by the Cheng Huang Family Trust under a Rule 10b5-1 trading plan adopted on September 5, 2025. The trust sold several blocks of shares at weighted average prices between approximately $135 and $143 per share in open market transactions. Following these sales, the trust held 6,387,370 ordinary shares, and Cheng Chi Fung also held 111,220 ordinary shares directly. The filing notes that he and his spouse are trustees of the trust and that he disclaims beneficial ownership except to the extent of their pecuniary interest.
Credo Technology Group Holding Ltd reported that its President and Chief Executive Officer, who is also a director, carried out multiple open-market sales of Ordinary Shares on January 7 and 8, 2026. The transactions were coded as sales and executed under a Rule 10b5-1 trading plan adopted on April 15, 2025, with individual trades priced using weighted-average sale prices across narrow intraday ranges, from $124.97 to $142.55 according to the footnotes.
After these sales, the reporting person held 270,641 Ordinary Shares directly. In addition, 1,882,502 Ordinary Shares were reported as held indirectly through The Brennan Family Trust, DTD 09/06/2002, with the reporting person disclaiming beneficial ownership of those shares except to the extent of his pecuniary interest.
Credo Technology Group Holding Ltd Chief Financial Officer Daniel W. Fleming reported planned insider sales of the company’s ordinary shares. On January 7, 2026, he sold 4,136 shares at a weighted average price of $128.0977 and 524 shares at $128.9892, in multiple trades within stated price ranges. On January 8, 2026, he sold 3,902 shares at a weighted average price of $140.1505, also through multiple trades. All of these sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on June 19, 2025. Following the reported transactions, Fleming directly owned 446,178 ordinary shares of Credo.
Credo (CRDO) reporting person William Joseph Brennan III filed a notice to sell up to 155,964 common shares through Goldman Sachs & Co. LLC, with an indicated aggregate market value of $21,990,924. The filing notes that 180,631,719 common shares were outstanding and lists NASD as the exchange.
The shares to be sold were acquired in several ways: 100,000 shares from a private transaction with the issuer on 01/22/2022, 46,488 restricted stock awards on 04/04/2024, and 9,476 restricted stock units on 01/05/2023. The filing also details multiple sales of Credo common shares during the past three months by Brennan and The Brennan Family Trust, including blocks of 50,000 shares and 18,016 shares sold on 10/30/2025 and 12/11/2025 for multi‑million‑dollar gross proceeds.
A holder of Credo common stock filed a notice of proposed sale under Rule 144 covering 8,562 common shares, to be sold through Goldman Sachs & Co. LLC on or about 01/07/2026 on the NASD market. The filing reports an aggregate market value of 1,207,242 for these shares, compared with 180,631,719 common shares outstanding.
The shares to be sold were acquired from the issuer as restricted stock unit compensation, including 4,660 shares acquired on 01/02/2026 and 3,902 shares acquired on 01/05/2026, both labeled as compensation. The filer also lists prior sales of Credo common stock during the past three months, including sales on 10/08/2025 such as 35,000 shares with gross proceeds of 4,822,303.5.
Credo Technology Group Holding Ltd Chief Financial Officer Daniel W. Fleming reported routine share withholding related to equity compensation. On January 2, 2026, 1,590 ordinary shares were withheld at $143.22 per share, and on January 5, 2026, a further 2,348 ordinary shares were withheld at $140.24 per share. According to the footnote, these shares were withheld by the company to cover tax obligations arising from the vesting and settlement of RSUs. Following these transactions, Fleming directly held 454,740 ordinary shares of Credo.
Credo Technology Group Holding Ltd insider Cheng Huang, a director and Chief Technology Officer, reported multiple sales of ordinary shares on December 15, 2025. The sales were made indirectly through the Cheng Huang Family Trust, which is controlled by Huang and his spouse as trustees and benefits their family. Each sale was reported as a disposition of shares at weighted average prices ranging from $141.7683 to $147.3859 per share, executed in multiple trades within specified price ranges.
The filing notes that these transactions were carried out under a Rule 10b5-1 trading plan adopted by the Cheng Huang Family Trust on September 6, 2024. After the reported transactions, Huang reported indirect beneficial ownership of 6,558,961 ordinary shares held by the trust.
Credo Technology Group Holding Ltd reported insider share sales by a director who also serves as Chief Operating Officer. On December 11, 2025, an affiliated entity, Zhan BVI Co Ltd, sold an aggregate of 370,000 Credo ordinary shares in multiple trades at weighted-average prices ranging from about $149.92 to $160.43 per share. These sales were made pursuant to a Rule 10b5-1 trading plan adopted on July 2, 2025.
After the transactions, Zhan BVI Co Ltd held 400,000 Credo ordinary shares. The reporting person also beneficially owned 2,622,055 ordinary shares directly and 125,000 ordinary shares indirectly through EZ Trust. The reporting person disclaims beneficial ownership of the indirectly held shares beyond any pecuniary interest.
Credo Technology Group Holding Ltd had a director who is also its President & Chief Executive Officer report multiple sales of ordinary shares. The transactions, made through The Brennan Family Trust, were executed on December 11, 2025 under a Rule 10b5-1 trading plan adopted on April 15, 2025. The reported weighted average sale prices for the various trades were based on executions within price ranges from $148.95 to $159.32 per share.
After the reported sales, the trust held 1,882,502 ordinary shares indirectly, while the insider also directly held 301,891 ordinary shares. The insider additionally reported a gift of 10,000 ordinary shares from The Brennan Family Trust to The Brennan Family Fund, a charitable remainder trust, and disclaimed beneficial ownership of the trust shares except to the extent of any pecuniary interest.